Care bundles in the management of COPD

Added July 16, 2020

Citation: Lloyd C, Garside J. Care bundles in the management of a COPD exacerbation. British Journal of Nursing. 2018 Jan 11;27(1):47-50.

Free to view pdf available here.

Free to view in journal: No

What is this? Patients with respiratory conditions, such as chronic obstructive pulmonary disease (COPD), may be at higher risk of complications of COVID-19 infection. Existing research on care bundles for managing COPD might provide useful information for patients, practitioners and policy makers.

In this integrative literature review, the authors searched for research on the effects on hospital readmission of care bundles in COPD patients. They restricted their search to studies published  between 2002 and 2017. They included 1 prospective cohort study, 1 interrupted time series analysis, 1 feasibility study, 1 systematic review, and 2 randomized trials.

What was found: Care bundles may reduce readmission and length of stay, and improve care quality for COPD patients, but the results of the research included in this review are inconsistent and inconclusive.

Common elements of care bundles include pharmacological interventions, smoking cessation programs, pulmonary rehabilitation and patient education.


Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.